Suryadevara, Carter M <br/><br/>
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  01 2019 
 - 358-368 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-1211  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD28 Antigens--genetics<br/>Heterografts<br/>Humans<br/>Immunotherapy, Adoptive<br/>Interleukin-2--genetics<br/>Mice<br/>Neoplasms--immunology<br/>Receptors, Chimeric Antigen--immunology<br/>Signal Transduction<br/>T-Lymphocytes, Regulatory--immunology<br/>Tumor Necrosis Factor Receptor Superfamily, Member 9--genetics